Home › Trial NCT05798533
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
- Trial IDNCT05798533
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorBGI, China
- Enrollment6
- Start date2023-01-10
- ConditionsSolid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.